Skip to main content
  • Contact Us
  • Vantage logo Sign Up
  • Subscriber Sign In
Evaluate Logo

navigation

  • COVID-19
    • COVID-19 Update
    • Evaluate Vantage COVID-19 Report
    • COVID-19 Stories from Evaluate Vantage
    • Evaluate’s Business Continuity Plan
  • What We Do
    • Commercial Intelligence
    • Products
      • EvaluatePharma
      • Evaluate Omnium
      • Japan Drug Forecasts
      • European Drug Forecasts
      • Epi Analyzer
    • Evaluate Custom Solutions
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Data Insights
      • Events
      • Medtech
      • Therapy Areas
      • Editorial Team
      • About Evaluate Vantage
  • How We Can Help You
    • Pharma and Biotech
    • Medtech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
    • Careers
      • Current Vacancies
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Subscriber Sign In

 

Vantage logo

Vantage

  • Covid-19
    • Covid-19 Coverage
    • Evaluate Vantage COVID-19 Report
  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Data Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas
  • About
    • Editorial team

Covid-19

Thumbnail
January 21, 2021

Lilly’s Blazes a trail in Covid-19 prevention

Thumbnail
January 21, 2021

Biopharma’s stock market winners and losers in 2020

Thumbnail
January 21, 2021

Lilly’s Blazes a trail in Covid-19 prevention

Thumbnail
January 21, 2021

Biopharma’s stock market winners and losers in 2020

Article image
Vantage logo
January 05, 2021

Atyr’s Covid-19 benefit claims raise questions

The group has blamed placebo “overperformance” on a high proportion of less-sick patients.

Article image
Vantage logo
December 31, 2020

Clinical developments over the Christmas period

Trial results in Covid-19 and cancer emerge, but little promise is seen.

Article image
Vantage logo
December 31, 2020

China joins the Covid-19 vaccine club with Sinopharm approval

Article image
Vantage logo
December 30, 2020

Amid questions, Astra bags UK Covid-19 vaccine approval

Article image
Vantage logo
December 21, 2020

Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability

An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.

Article image
Vantage logo
December 18, 2020

The sellside has picked a winning Covid-19 vaccine – for now

Article image
Vantage logo
December 16, 2020

A new setting for antigen testing

It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.

Article image
Vantage logo
December 15, 2020

Moderna aching for vaccine success

Article image
Vantage logo
December 14, 2020

Incyte’s Jakafi disappoints in severe Covid-19

As Jak inhibition takes a big knock, attention turns to other immunosuppressive mechanisms being studied in very ill Covid-19 patients.

  • Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
Article image
Vantage logo
January 05, 2021

Atyr’s Covid-19 benefit claims raise questions

The group has blamed placebo “overperformance” on a high proportion of less-sick patients.

Article image
Vantage logo
December 31, 2020

Clinical developments over the Christmas period

Trial results in Covid-19 and cancer emerge, but little promise is seen.

Article image
Vantage logo
December 31, 2020

China joins the Covid-19 vaccine club with Sinopharm approval

Article image
Vantage logo
December 30, 2020

Amid questions, Astra bags UK Covid-19 vaccine approval

Article image
Vantage logo
December 21, 2020

Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability

An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.

Article image
Vantage logo
December 18, 2020

The sellside has picked a winning Covid-19 vaccine – for now

Article image
Vantage logo
December 16, 2020

A new setting for antigen testing

It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.

Article image
Vantage logo
December 15, 2020

Moderna aching for vaccine success

Article image
Vantage logo
December 14, 2020

Incyte’s Jakafi disappoints in severe Covid-19

As Jak inhibition takes a big knock, attention turns to other immunosuppressive mechanisms being studied in very ill Covid-19 patients.

  • Load More
Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up

Latest Reports

December 10, 2020

Evaluate Vantage 2021 Preview

July 29, 2020

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020

View more...

Editor's Picks

Vantage logo
December 10, 2020

What the coming year might hold for biopharma

Vantage logo
December 11, 2020

Covid-19 vaccine developers remind the world that setbacks happen

Vantage logo
December 09, 2020

Astrazeneca’s vaccine looks increasingly like an also-ran

Vantage logo
November 09, 2020

Pfizer and Biontech snatch first Covid vaccine victory

Vantage logo
December 01, 2020

The promise and the perils of antigen testing

Open modal

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-(0)80-1164-4754

Footer menu

  • Terms and Conditions
  • Privacy Policies
  • Cookie Policy

© Copyright 2021 Evaluate Ltd.